blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1328543

EP1328543 - NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A & B [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.06.2010
Database last updated on 31.08.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): TR
published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena (SI) / IT
For all designated states
J. Craig Venter Institute, Inc.
9704 Medical Center Drive
Rockville, MD 20850 / US
[2009/33]
Former [2008/37]For all designated states
Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena SI / IT
For all designated states
J. Craig Venter Institute, Inc.
9704 Medical Center Drive
Rockville, MD 20850 / US
Former [2007/04]For all designated states
Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena SI / IT
For all designated states
THE INSTITUTE FOR GENOMIC RESEARCH
9712 Medical Center Drive
Rockville, Maryland 20850 / US
Former [2003/46]For all designated states
Chiron SRL.
Via Fiorentina, 1
53100 Siena / IT
For all designated states
THE INSTITUTE FOR GENOMIC RESEARCH
9712 Medical Center Drive
Rockville, Maryland 20850 / US
Former [2003/30]For all designated states
Chiron S.p.A.
Via Fiorentina, 1
53100 Siena / IT
For all designated states
THE INSTITUTE FOR GENOMIC RESEARCH
9712 Medical Center Drive
Rockville, Maryland 20850 / US
Inventor(s)01 / TELFORD, John
Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina, 1
I-53100 Siena / IT
02 / MASIGNANI, Vega
Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina, 1
I-53100 Siena / IT
03 / MARGARIT Y ROS, Immaculada
Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina, 1
I-53100 Siena / IT
04 / GRANDI, Guido
Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina, 1
I-53100 Siena / IT
05 / FRASER, CLAIRE
The Institute for Genomic Research, INC. 9712 Medical Center Drive
Rockville, MD 20850 / US
06 / TETTELIN, Hervé
The Institute for Genomic Research, INC. 9712 Medical Center Drive
Rockville, MD 20850 / US
 [2009/18]
Former [2003/30]01 / TELFORD, John, Chiron S.p.a
Via Fiorentina, 1
I-53100 Siena / IT
02 / MASIGNANI, Vega, Chiron S.p.a
Via Fiorentina, 1
I-53100 Siena / IT
03 / MARGARIT Y ROS, Immaculada, Chiron S.p.a
Via Fiorentina, 1
I-53100 Siena / IT
04 / GRANDI, Guido, Chiron S.p.a
Via Fiorentina, 1
I-53100 Siena / IT
05 / FRASER, CLAIRE, The Institute for Genomic Research
9712 Medical Center Drive
Rockville, MD 20850 / US
06 / TETTELIN, Hervé, The Inst. for Genomic Research
9712 Medical Center Drive
Rockville, MD 20850 / US
Representative(s)Marshall, Cameron John, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2009/51]Marshall, Cameron John, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Former [2003/30]Marshall, Cameron John, et al
Carpmaels & Ransford 43 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date01982584.329.10.2001
[2003/30]
WO2001GB04789
Priority number, dateGB2000002633327.10.2000         Original published format: GB 0026333
GB2000002872724.11.2000         Original published format: GB 0028727
GB2001000564007.03.2001         Original published format: GB 0105640
[2003/30]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0234771
Date:02.05.2002
Language:EN
[2002/18]
Type: A2 Application without search report 
No.:EP1328543
Date:23.07.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 02.05.2002 takes the place of the publication of the European patent application.
[2003/30]
Type: B1 Patent specification 
No.:EP1328543
Date:12.08.2009
Language:EN
[2009/33]
Search report(s)International search report - published on:EP16.01.2003
ClassificationIPC:C07K14/315
[2003/30]
CPC:
C07K14/315 (EP,US); A61K39/092 (US); A61P1/02 (EP);
A61P15/00 (EP); A61P21/00 (EP); A61P27/16 (EP);
A61P29/02 (EP); A61P31/04 (EP); A61P31/10 (EP);
A61P31/12 (EP); A61P31/14 (EP); A61P33/02 (EP);
A61P37/04 (EP); A61P43/00 (EP); C07K16/1275 (US);
C07K16/40 (US); C12N9/1088 (EP,US); A61K2039/505 (EP,US);
A61K2039/53 (EP,US); A61K38/00 (EP,US); A61K39/00 (EP,US);
C07K2319/00 (EP,US); C12Y205/01018 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/30]
Extension statesAL31.03.2003
LT31.03.2003
LV31.03.2003
MK31.03.2003
RO31.03.2003
SI31.03.2003
TitleGerman:NUKLEINSÄUREN UND PROTEINE VON GRUPPEN A UND B-STREPTOKOKKEN[2003/30]
English:NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A & B[2003/30]
French:ACIDES NUCLEIQUES ET PROTEINES DERIVES DES GROUPES DE STREPTOCOQUES A ET B[2003/30]
Entry into regional phase31.03.2003National basic fee paid 
31.03.2003Designation fee(s) paid 
31.03.2003Examination fee paid 
Examination procedure23.05.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
31.03.2003Examination requested  [2003/30]
23.01.2006Despatch of a communication from the examining division (Time limit: M04)
18.05.2006Reply to a communication from the examining division
06.08.2007Despatch of a communication from the examining division (Time limit: M06)
25.03.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
30.04.2008Reply to a communication from the examining division
30.01.2009Cancellation of oral proceeding that was planned for 03.02.2009
30.01.2009Minutes of oral proceedings despatched
03.02.2009Date of oral proceedings
03.02.2009Date of oral proceedings (cancelled)
04.02.2009Despatch of a communication from the examining division (Time limit: M01)
09.02.2009Reply to a communication from the examining division
03.04.2009Communication of intention to grant the patent
17.06.2009Fee for grant paid
17.06.2009Fee for publishing/printing paid
Divisional application(s)EP06075446.2  / EP1671981
EP09004551.9  / EP2189473
EP10179723.1  / EP2284181
EP10179728.0  / EP2284182
EP10179732.2  / EP2277894
EP10179737.1  / EP2277895
EP10179740.5  / EP2284183
EP10179744.7  / EP2277896
EP15154238.8  / EP2896629
Opposition(s)17.05.2010No opposition filed within time limit [2010/29]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
30.04.2008Request for further processing filed
30.04.2008Full payment received (date of receipt of payment)
Fees paidRenewal fee
31.03.2003Renewal fee patent year 03
25.10.2004Renewal fee patent year 04
07.10.2005Renewal fee patent year 05
05.10.2006Renewal fee patent year 06
12.10.2007Renewal fee patent year 07
31.03.2008Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipFI12.08.2009
TR12.08.2009
GR13.11.2009
PT12.12.2009
[2011/44]
Former [2010/47]FI12.08.2009
GR13.11.2009
PT12.12.2009
Former [2010/16]FI12.08.2009
PT12.12.2009
Former [2010/09]FI12.08.2009
Cited inInternational search[X]WO9801561  (TRINITY COLLEGE DUBLIN [IE], et al);
 [X]WO9823631  (SMITHKLINE BEECHAM CORP [US], et al);
 [X]WO9916882  (MEDIMMUNE INC [US]);
 [PX]WO0132882  (MICROBIAL TECHNICS LTD [GB], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.